Adopting the advice of its Advisory Committee on Immunization Practices, the Centers for Disease Control and Prevention last night recommended the Pfizer-BioNTech vaccine for children aged 12 to 15, paving the way for providers to begin vaccinating them immediately. The Food and Drug administration Monday authorized emergency use of the vaccine in this age group. 

“I encourage parents with questions to talk to your child’s healthcare provider or your family doctor to learn more about the vaccine,” said CDC Director Rochelle Walensky, M.D. “And if your adolescent is behind on routinely recommended vaccines due to the pandemic or for other reasons, now would be a good time to work with your child’s nurse or doctor to make sure they get caught up.”

CDC tomorrow will host a call for clinicians on the recommendations and clinical guidance for using the Pfizer-BioNTech vaccine in this age group. The agency plans to post a recording a few hours after the 2 p.m. ET call for those unable to attend. 
 

FDA previously authorized the vaccine for Americans aged 16 and older.

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…